Evidence map›Paper›PMID 22516480›Full record

ReviewChinese journal of cancer2012

A case report of primary small cell carcinoma of the breast and review of the literature.

Qi-Dong Ge, Ning Lv, Yun Cao, Xi Wang, Jun Tang, Ze-Ming Xie, Xiang-Sheng Xiao, Peng Liu, Xiao-Ming Xie, Wei-Dong Wei

Abstract readCase ReportsReview
In one paragraph

Review in Chinese journal of cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Primary small cell carcinoma of the breast: a case report.Journal of medical case reports · 2017
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Qi-Dong GeDepartment of Breast Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China. weiweid@mail.sysu.edu.cn
Ning Lv
Yun Cao
Xi Wang
Jun Tang
Ze-Ming Xie
Xiang-Sheng Xiao
Peng Liu
Xiao-Ming Xie
Wei-Dong Wei

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary small cell carcinoma (SCC) of the breast, an exceedingly rare and aggressive tumor, is often characterized by rapid progression and poor prognosis. We report a case of primary SCC of the breast that was diagnosed through pathologic and immunohistochemical examinations. Computed tomography (CT) scans failed to reveal a non-mammary primary site. Due to the scant number of relevant case summaries, this type of tumor is proved to be a diagnostic and therapeutic challenge. Therefore, we also reviewed relevant literature to share expertise in diagnosis, clinicopathologic characteristics, treatment, and prognosis of this type of tumor. Future studies with more cases are required to define more appropriate treatment indications for this disease.

Indexed as

AdultAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsCarboplatinCarcinoma, Intraductal, NoninfiltratingCarcinoma, Small CellCD56 AntigenDocetaxelFemaleHumansLymphatic MetastasisMammographyNuclear ProteinsPhosphopyruvate HydrataseSynaptophysinTaxoidsCarboplatinCD56 AntigenDocetaxelNuclear ProteinsPhosphopyruvate HydrataseSynaptophysinTaxoidsThyroid Nuclear Factor 1Transcription Factors

Identifiers

PMID22516480
PMCPMC3777496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.